InvestorsHub Logo
Followers 12
Posts 2443
Boards Moderated 0
Alias Born 05/31/2017

Re: Clutch29 post# 1945

Friday, 03/27/2020 5:20:04 PM

Friday, March 27, 2020 5:20:04 PM

Post# of 3011
Well?

During the year ended December 31, 2019 the Company recognized revenue of $4,368,000 as consideration in exchange for conveyance of intellectual property rights at the signing of the agreement, $1,838,000 for research and development activities related to its influenza A/B program and $358,000 for program expense reimbursements.

 

The company recognized revenue for the year ended December 31, 2019 and 2018 were $6,564,000 and $0, respectively. As of December 31, 2019, accounts receivable of $644,000 was due from Merck

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent COCP News